Director Clinical Imaging Jobs (NOW HIRING)

Imaging and dosimetry strategy 

• Develop clinical imaging and dosimetry strategies designed to support clinical development plans for ARTBIO's RLT agents. 

• Design and implement imaging protocols, plans and procedures for clinical studies. 

• Define quantitative imaging standards across the portfolio, including acquisition and reconstruction parameters, calibration and QC frameworks, and site qualification criteria for SPECT/CT and PET/CT. 

• Oversight of dosimetry methodology: segmentation and registration, time-activity curve fitting, time-integrated activity estimation, and organ- and lesion-level absorbed dose calculation. 

• Evaluate and integrate emerging imaging methods, including surrogate-isotope approaches and automated lesion segmentation. 

Trial documentation and design 

• Author imaging charters, site imaging manuals, data transmittal specifications and analysis plans. 

• Contribute imaging and dosimetry content to protocols, amendments, schedules of assessment, informed consent forms, Investigator's Brochures and clinical study reports. 

Site and vendor execution 

• Provide oversight and guidance for all aspects of Medical Imaging for clinical trials. 

• Oversee site imaging feasibility, qualification and activation, including equipment surveys, phantom acceptance, test transmissions, and cross-calibration between dose calibrator and camera. 

• Deliver training on imaging requirements and response criteria to investigators, technologists, study teams and CRAs, and at investigator meetings. 

• Oversee CRO vendors including imaging core labs and dosimetry vendors.  

• Manage the resolution of technical, radiological and dosimetry questions and issues on a study and program level. 

Regulatory, scientific and external engagement 

• Deliver subject matter expertise regarding advanced imaging techniques (including PET/CT, SPECT/CT, MRI, CT and other modalities as needed), image evaluation, and dosimetry estimation. 

• Support health authority interactions on imaging and dosimetry, including IND/CTA content and responses to agency questions. 

• Lead imaging and dosimetry academic collaborations, contractor and vendor/partner interactions, and build and maintain a network of external experts to inform protocol design. 

• Provide scientific and technical support and oversight in research activities. 

• Contribute to abstracts, posters, manuscripts and scientific presentations. 

• Advanced degree (MSc, PhD or MD) in medical physics, nuclear medicine physics, biomedical engineering, radiochemistry or a closely related discipline. An equivalent clinical qualification (nuclear medicine physician, certified medical physicist or senior nuclear medicine technologist) with commensurate clinical trial experience will also be considered. 

• Minimum 5 years of relevant industry experience for appointment at Associate Director; 8 or more years for appointment at Director. 

• Direct experience designing and managing imaging aspects of clinical protocols for oncology radiopharmaceutical agents, including study design, endpoint selection, dosimetry, harmonisation between clinical sites and imaging core lab oversight. 

• Specific experience with imaging study design and direct or indirect estimation of normal organ and tumour dosimetry for early-stage clinical development of RLT agents. 

• Demonstrated expertise in quantitative SPECT/CT and PET/CT in a clinical setting. 

• Working knowledge of internal dosimetry principles. 

• Experience authoring imaging charters and site imaging manuals to regulatory standards 

• Experience selecting and governing imaging CROs, core laboratories or dosimetry vendors. 

• Fluency in oncology response assessment, including RECIST 1.1, PCWG and molecular imaging response frameworks. 

• Experience contributing imaging or dosimetry content to IND/CTA submissions and responses to health authority questions. 

Preferred 

• Direct experience with 212Pb, or with other alpha emitters. 

• Experience with elementally matched imaging surrogates for treatment planning, including 203Pb. 

• Prostate cancer experience, and familiarity with PSMA PET tracers and response criteria.  

• First-in-human and dose-escalation experience. 

• Prior experience at an imaging CRO or imaging core laboratory. 

Personal Attributes 

• Proactive, detail-oriented, and eager to learn. 

• Comfortable working in a fast-paced biotech environment; hands-on and self-directed. 

• Team player who thrives on collaboration and cross-functional flexibility. 

• Demonstrated ability to work well under pressure, both independently and as part of a team. 

• Strong organisational, planning, and time management skills. 

• Commitment to safety, continuous improvement, and staying current with industry trends and advances. 

What We Offer 

• A unique chance to contribute to first-in-class cancer therapies. 

• Exposure to both imaging and clinical development in a dynamic biotech setting. 

• Hands-on training and professional development opportunities. 

• An international, collaborative, and supportive work culture. 

• Competitive compensation and benefits.